Why Great Science Is Just a Start
I know firsthand that today’s buyers are overwhelmed.
You cannot escape emails, webinars, white papers, LinkedIn messages, and chatbot prompts, and you have not had your morning coffee yet.
The average professional receives 121 emails per day,1 and B2B buyers now consume 13 or more pieces of content before making a purchasing decision.2 Their attention is the most valuable commodity.
And for life sciences and healthcare organizations, there are added levels of complexity, and cutting through the clutter isn’t just a creative challenge, it’s a strategic imperative.
Attention is the New Currency in B2B
Attention spans of humans are shrinking, which is a coping mechanism, and data supports it.
A study found that the average attention span is now just 8 seconds, shorter than that of a goldfish.3 When targeting time-constrained healthcare executives, physicians, or procurement leads, you would be lucky to get one chance. Getting a second is wishful thinking..
I have found that in life sciences, if your story doesn’t resonate immediately, you’re ignored. And in a market where only 5% of your audience is actively “in-market” at any given time,4 the rest will scroll past unless there is a reason to remember you.
How To Win Attention in Life Sciences & Healthcare Marketing
After more than 15 years, we have learned the following lessions:
1. Lead with Clarity, Not Complexity
Your product might be technically brilliant, but that shine will be lost if your audience doesn’t understand it in the first 10 seconds.
Whether you are introducing a new molecular diagnostic or an AI-driven clinical platform, your value proposition must be crystal clear and customer-centric.
Instead of:
“A novel multi-omic assay leveraging deep learning and spectral imaging…”
try:
“Get faster, more accurate results with fewer unnecessary biopsies.”
2. Hook Emotionally, Back It Scientifically
Even in B2B, decisions are driven by emotion and then justified with logic. Start with stakes, outcomes, or what’s at risk if the audience does nothing. Then deliver the technical proof to build trust.
Avoid:
“Our AI-enabled platform analyzes complex datasets to streamline biomarker discovery and accelerate clinical decision-making.”
Why it’s ineffective:
This starts with technical features and jargon. It doesn’t tell the reader why it matters, what’s at stake, or how it solves a real pain point.
Better Worded Sentence (Emotion-First, Logic-Supported):
“Every delay in biomarker validation costs time patients don’t have. That’s why our AI-driven platform helps teams cut through complex datasets and identify targets faster with the scientific rigor needed for clinical confidence.”
Why it works:
It begins with what is at risk (patient time, lost opportunity), then presents the solution and adds credibility.
3. Use Micro-Content to Pull People In
According to the Content Marketing Institute, 72% of successful B2B marketers prioritize short-form video, infographics, and snackable posts.5 These formats give your audience quick looks and earn you more attention over time.
4. Build a Narrative That Sticks
Data matters, but narrative moves people. A Harvard study showed that stories are 22 times more memorable than facts alone.6 We connect your innovation to a broader mission, like earlier intervention, health equity, or efficiency gains, to make it stick.
Poorly Worded Sentence (Fact-Heavy, Story-Lacking):
“Our platform improves care coordination by integrating clinical data from multiple sources, reducing manual errors by 35%.”
Why it’s ineffective:
It’s technically informative but emotionally flat. It doesn’t tell why it matters or connect to a larger mission.
Better Worded Sentence (Narrative-Driven, Still Credible):
“When a patient’s diagnosis is delayed because data sits in silos, outcomes suffer. Our platform brings fragmented information together, improving coordination, reducing errors, and helping clinicians intervene when it still makes a difference.”
Why it works:
It starts with a relatable moment (a delayed diagnosis), appeals to purpose and patient impact, and then supports the claim with functional benefits. It tells a mini-story with stakes.
Why This Matters for Life Sciences Marketers Right Now
The old reliance on PDF downloads, generic campaigns, and overloaded slide decks is no longer effective. Stakeholders have less time, more demands, and higher expectations. To reach and influence them, you need:
- Speed and simplicity in your messaging
- Multi-format content tailored to busy buyers so they can choose the format they prefer
- A clear, emotional, and commercial value proposition
Many agencies struggle in life sciences due to a lack of understanding of the underlying science and technical complexity. You cannot sell what you don’t understand. Effective marketing in life sciences, diagnostics, MedTech, and Healthtech requires the ability to translate complex ideas into clear, compelling value propositions, develop content that engages rather than overwhelms, and reach the right stakeholders with precision and credibility.
References:
-
-
-
- Campaign Monitor. Resources. Knowledge Base.
- B2B Buying Process: What You Need to Know.
- Golden Steps ABA. Average Human Attention Span (Statistics).
- LinkedIn B2B Institute. The 95:5 Rule for B2B Marketing.
- Content Marketing Institute. B2B Content Marketing Benchmarks, Budgets, and Trends (2024).
- Harvard Business Review. Why Your Brain Loves Good Storytelling (2014).
-
-
By Teri Krause, VP Operations & Client Services
Teri Krause is a healthcare and life sciences marketing strategist with more than a decade of experience helping organizations elevate visibility, strengthen relationships, and drive growth. At BTS Consulting, she manages client relationships, oversees vendor deliverables, and partners with creative teams to deliver high-quality campaigns. Teri has led successful initiatives for leading pharma, biotech, diagnostics, and medical device companies, as well as hospitals, insurers, and nonprofits. Her work has supported national campaigns, product launches, and branding strategies for organizations including Exact Sciences, QIAGEN, GE Medical, Mayo Clinic, and United Healthcare.

